Shunyata Pain
- Chronic Pain
- Endometriosis
- Fibromyalgia
- Inflammation
- Migraines
- Neuropathic Pain / Nerve Damage
- Severe Arthritis
DOSAGE RECOMMENDATIONS
Patients should begin with a dose of approximately 2.5mg THC and 2.5mg CBD- Approx. 10 drops.
- Approx. 10 additional drops.
Shunyata Calm
- Acute Pain
- Amyotrophic Lateral Sclerosis (ALS)
- Arthritis
- Crohn’s Disease
- Depression
- Epilepsy
- Inflammation
- Inflammatory Bowel Disease (IBD)
- Insomnia / Sleep Disorders
- Irritable Bowel Syndrome (IBS)
- Menstrual Pain/Cramping
- Multiple Sclerosis (MS)
- Palliative Care
- Parkinson’s Disease
- Polycystic Ovary Syndrome (PCOS)
- Post Traumatic Stress Disorder (PTSD)
- Seizure Disorders
- Spasticity
- Spinal Injuries
DOSAGE RECOMMENDATIONS
Patients should begin with a dose of approximately 5mg THC and 5mg CBD- Approx. 15 drops.
- Approx. 15 additional drops.
Shunyata Balance
- Attention Deficit Hyperactivity Disorder (ADHD)
- Anxiety
- Autism Spectrum Disorder (ASD)
- Autoimmune Disorder
- Bipolar Disorder
- Cachexia / Poor Appetite
- Chronic Fatigue
- HIV / AIDS
- Inflammation
- Mood Disorders
- Nausea and Vomiting
- Stress
DOSAGE RECOMMENDATIONS
Patients should begin with a dose of approximately 2.5mg THC and 2.5mg CBD
- Approx. 10 drops.
If needed, dosage can be increased in increments of an additional 2.5mg of THC and 2.5mg of CBD, once per day.
- Approx. 10 additional drops.
*NOTE: While the total number of drops in some cases can seem a bit high, it is not uncommon for patients to consume a full 1ml of medical cannabis infused oil in a single dose. Also note, when using full-spectrum products, the terpene profile should be considered when recommending products for either daytime or evening use.
Dosage Directions
DETAILED DOSAGE DIRECTIONS COMING SOON!
How are cannabis medicine products made?
Novel cannabis medicines currently available for prescription use in India are classified as ingestible infused cannabis oils.
Cannabis oils are made using a variety of different methods, typically requiring the following steps:
The primary cannabinoids used in medical cannabis treatment, THC and CBD, must first be ‘activated’ by converting the THC-A and CBD-A found within harvested raw cannabis. This process is achieved by using heat to convert THC-A and CBD-A into Delta9-THC and CBD.
Extraction is the process by which concentrated whole-plant cannabis resin is removed from the harvested plant material. This resin contains a high percentage of therapeutic cannabinoids and terpenes. This extraction process is often performed using:
- Ethanol
- C02
- Butane
- Ice and Water
While each of these methods are capable of achieving comparable results, some are more effective at recovering high potencies of cannabinoids and terpenes.
In order for cannabinoids to be processed and absorbed by the body, they first need to be infused with a fatty-oil/fatty-acid. This is done by exposing a mixture of cannabis resin and carrier oil to low heat while mixing. The resulting mixture will have a consistent cannabinoid potency. Common carrier oils used to manufacture ingestible oils include:
- MCT (Medium Chain Triglycerides)
- Grape Seed Oil
- Sunflower Seed Oil
